美洲梧桐
2019-03-20
$AbbVie Inc.(ABBV)$.fda对abbv药品监控是利好还是利空。
免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP，发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":434737,"tweetId":"434737","gmtCreate":1553017844820,"gmtModify":1704793743135,"author":{"id":3442522168671508,"authorId":3442522168671508,"authorIdStr":"3442522168671508","name":"美洲梧桐","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":3,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>$AbbVie Inc.(ABBV)$.fda对abbv药品监控是利好还是利空。</p></body></html>","htmlText":"<html><head></head><body><p>$AbbVie Inc.(ABBV)$.fda对abbv药品监控是利好还是利空。</p></body></html>","text":"$AbbVie Inc.(ABBV)$.fda对abbv药品监控是利好还是利空。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/434737","repostId":0,"isVote":1,"tweetType":1,"viewCount":1577,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["ABBV"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":51,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/434737"}
精彩评论